Advisors Asset Management Inc. reduced its stake in Agilent Technologies, Inc. (NYSE:A) by 15.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 46,236 shares of the medical research company’s stock after selling 8,521 shares during the period. Advisors Asset Management Inc.’s holdings in Agilent Technologies were worth $2,968,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Quantbot Technologies LP boosted its stake in shares of Agilent Technologies by 267.5% in the 3rd quarter. Quantbot Technologies LP now owns 150,421 shares of the medical research company’s stock valued at $9,657,000 after purchasing an additional 109,485 shares in the last quarter. Russell Investments Group Ltd. raised its holdings in Agilent Technologies by 91.9% in the 3rd quarter. Russell Investments Group Ltd. now owns 371,428 shares of the medical research company’s stock valued at $23,847,000 after buying an additional 177,891 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. raised its holdings in Agilent Technologies by 9.9% in the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 998,225 shares of the medical research company’s stock valued at $64,086,000 after buying an additional 90,317 shares during the last quarter. Signature Estate & Investment Advisors LLC raised its holdings in Agilent Technologies by 14.3% in the 3rd quarter. Signature Estate & Investment Advisors LLC now owns 10,633 shares of the medical research company’s stock valued at $683,000 after buying an additional 1,333 shares during the last quarter. Finally, Comerica Bank raised its holdings in Agilent Technologies by 19.3% in the 3rd quarter. Comerica Bank now owns 98,592 shares of the medical research company’s stock valued at $6,654,000 after buying an additional 15,973 shares during the last quarter.

A has been the subject of a number of research reports. Zacks Investment Research upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 price objective for the company in a report on Tuesday, October 10th. Deutsche Bank AG set a $68.00 price objective on shares of Agilent Technologies and gave the company a “buy” rating in a report on Wednesday, August 16th. Janney Montgomery Scott raised their price objective on shares of Agilent Technologies from $65.00 to $70.00 and gave the company a “buy” rating in a report on Wednesday, August 16th. BidaskClub lowered shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 12th. Finally, Jefferies Group LLC reiterated a “buy” rating and issued a $66.00 price objective on shares of Agilent Technologies in a report on Wednesday, August 9th. Five research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $68.34.

In other news, Director Boon Hwee Koh sold 4,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $63.63, for a total transaction of $286,335.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Michael R. Mcmullen sold 22,481 shares of the firm’s stock in a transaction that occurred on Monday, November 20th. The stock was sold at an average price of $70.00, for a total transaction of $1,573,670.00. Following the sale, the chief executive officer now directly owns 327,882 shares of the company’s stock, valued at approximately $22,951,740. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 107,709 shares of company stock valued at $7,195,576.

Agilent Technologies, Inc. (NYSE:A) opened at $69.36 on Friday. The company has a current ratio of 3.30, a quick ratio of 2.76 and a debt-to-equity ratio of 0.37. Agilent Technologies, Inc. has a fifty-two week low of $42.92 and a fifty-two week high of $70.81. The stock has a market cap of $22,106.37, a P/E ratio of 28.98, a price-to-earnings-growth ratio of 2.07 and a beta of 1.27.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.62 by $0.05. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.96%. The firm had revenue of $1.19 billion during the quarter, compared to analyst estimates of $1.17 billion. During the same quarter last year, the business earned $0.59 EPS. The company’s revenue was up 7.0% compared to the same quarter last year. sell-side analysts forecast that Agilent Technologies, Inc. will post 2.58 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 24th. Shareholders of record on Tuesday, January 2nd will be issued a dividend of $0.149 per share. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.13. The ex-dividend date is Friday, December 29th. This represents a $0.60 annualized dividend and a yield of 0.86%. Agilent Technologies’s dividend payout ratio (DPR) is presently 25.24%.

COPYRIGHT VIOLATION WARNING: This article was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another site, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://www.watchlistnews.com/agilent-technologies-inc-a-shares-sold-by-advisors-asset-management-inc/1725445.html.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.